Professor Andrew James Michael Boulton stands as a preeminent authority in diabetes research and clinical medicine with global influence spanning over three decades. He currently serves as Professor of Medicine at the University of Manchester and holds a visiting professorship at the University of Miami School of Medicine while practicing as a Consultant Physician at Manchester Royal Infirmary. A graduate of Newcastle-upon-Tyne, Professor Boulton previously held significant academic positions at the University of Miami where he served from 1986 to 1995 and again from 2002 to 2004 before establishing his distinguished career in the UK. His leadership extends beyond clinical practice as he currently serves as President of the International Diabetes Federation and Chair of EURADIA: Alliance for European Diabetes Research, shaping global diabetes policy and research directions.
Professor Boulton's scholarly contributions have fundamentally advanced understanding of diabetic complications, particularly in the critical areas of lower extremity and renal pathologies that significantly impact patient quality of life and mortality. With an impressive publication record exceeding 550 peer-reviewed manuscripts and an H-Index surpassing 130, his research has established foundational knowledge in diabetic foot care and complication management. As director of the DIALEX Diabetes Lower Extremity Research Group, he has pioneered systematic approaches to diabetic limb salvage that have been adopted in clinical guidelines worldwide. His work has received international recognition including the prestigious ADA's Roger Pecoraro Lectureship and the EASD Camillo Golgi prize, reflecting the profound impact of his contributions on diabetes care standards globally.
Despite entering a part-retired phase of his career, Professor Boulton continues to actively mentor the next generation of diabetes researchers, currently supervising multiple PhD and MD students at the University of Manchester. His enduring influence is evident in his editorial roles as senior associate editor of Diabetes Care and former editor of Diabetic Medicine, where he has shaped scientific discourse in the field for decades. In 2019, he was recognized as the number one UK diabetes researcher in the field of complications, cementing his status as a leading figure whose work continues to guide clinical practice and research priorities. Professor Boulton's legacy extends through his numerous awards including the ADA's Harold Rifkin Award for distinguished international service and the International Diabetes Endocrinologist Award, ensuring his contributions will continue to influence diabetes care for generations to come.
